/Investor DB

BioHealth Innovation, Inc. — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Palleon Pharmaceuticalspalleonpharma.comin𝕏Series A · Oct 2017 · $48M

Palleon Pharma develops small molecule and biologic drugs targeting autoimmune and inflammatory diseases using proprietary glycoscience platforms.

BiotechDigital HealthMedical DevicesWaltham, US

Jim Broderick(Co-Founder)inJohn Hennessy(Executive Officer)Karen Hong(Director)James Lee(Director)Stephen Hoffman(Director)Li Peng(Chief Scientific Officer)

Co-investorsMatrix Capital ManagementPfizer VenturesPfizer Venture InvestmentsSR One Capital ManagementTakeda VenturesVertex Ventures HC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.